HPV Knowledge, Attitudes, and Vaccination Among Hispanic/Latino College Students in the USA

This study evaluated Human Papillomavirus-related knowledge and attitudes, vaccination practices, and explored associated factors among Hispanic/Latino college students in the United States of America. Using a self-administered survey, a descriptive, cross-sectional quantitative study was conducted in 2018 at colleges and universities in the United States of America. Our results indicate that Hispanic/Latino college students had a low level of HPV-related knowledge, a moderately positive attitude, and a moderate rate of HPV vaccination. Students who were in a health-related major, married/divorced, and had health insurance had greater knowledge and more positive attitudes towards HPV and its vaccines. This study is important due to the disproportionate high rate of HPV associated cervical cancers among Hispanic/Latinos when compared to other races and ethnicities. Our findings will inform the development of innovative intervention to promote HPV vaccination uptake across educational institutions

Motivation to Consent and Adhere to the FORT Randomized Controlled Trial

The aim of this qualitative study was to identify the motivational factors that influence cancer survivors to participate and adhere to the fear of cancer recurrence (FCR) FORT randomized controlled trial (RCT). Fifteen women diagnosed with breast and gynecological cancer who took part in the FORT RCT were interviewed about their experience to consent and adhere to the trial. The transcribed interviews were content analyzed within a relational autonomy framework. The analysis revealed that the participants’ motivation to consent and adhere to the FORT RCT was structured around thirteen subthemes grouped into four overarching themes: (1) Personal Influential Factors; (2) Societal Motivations; (3) Structural Influences; and (4) Gains in Emotional Support. The unique structures of the trial such as the group format, the friendships formed with other participants in their group and with the group leaders, and the right timing of the trial within their cancer survivorship trajectory all contributed to their motivation to consent and adhere to the FORT RCT. While their initial motivation to participate was mostly altruistic, it was their personal gains obtained over the course of the trial that contributed to their adherence. Potential gains in emotional and social support from psycho-oncology trials should be capitalized when approaching future participants as a mean to improve on motivations to consent and adhere